C07D 233/96
Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other
Official title: having three double bonds between ring members or between ring members and non-ring members
C07D233/96 (Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other) appears on 193 US grants and 124 published applications in this corpus.
Search patents in C07D- Granted patents
- 193
- Published applications
- 124
- Assignees
- 141
- Inventors
- 621
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 8 | 0 |
| 1978 | 6 | 0 |
| 1979 | 4 | 0 |
| 1980 | 4 | 0 |
| 1981 | 4 | 0 |
| 1982 | 4 | 0 |
| 1983 | 2 | 0 |
| 1984 | 3 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 3 | 0 |
| 1988 | 2 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 3 | 0 |
| 1992 | 2 | 0 |
| 1993 | 4 | 0 |
| 1994 | 7 | 0 |
| 1995 | 8 | 0 |
| 1996 | 10 | 0 |
| 1997 | 4 | 0 |
| 1998 | 0 | 0 |
| 1999 | 4 | 0 |
| 2000 | 6 | 0 |
| 2001 | 7 | 3 |
| 2002 | 9 | 10 |
| 2003 | 7 | 5 |
| 2004 | 2 | 6 |
| 2005 | 5 | 6 |
| 2006 | 7 | 3 |
| 2007 | 2 | 4 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 4 |
| 2011 | 1 | 1 |
| 2012 | 0 | 3 |
| 2013 | 1 | 5 |
| 2014 | 4 | 5 |
| 2015 | 4 | 1 |
| 2016 | 3 | 7 |
| 2017 | 1 | 3 |
| 2018 | 4 | 3 |
| 2019 | 3 | 3 |
| 2020 | 2 | 10 |
| 2021 | 6 | 8 |
| 2022 | 5 | 3 |
| 2023 | 3 | 10 |
| 2024 | 8 | 9 |
| 2025 | 2 | 5 |
| 2026 | 6 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Thiohydantoin derivatives and uses thereof25 Aug 2026US 12,714,694 B2Celros Biotech
- PSMA imaging agents24 Mar 2026US 12,583,887 B2Siemens Medical Solutions USA, Inc.
- PSMA imaging agents24 Feb 2026US 12,559,521 B2Siemens Medical Solutions USA, Inc.
- 1-alkyl-5-arylidene-2-selenoxoimidazolidine-4-on and derivative thereof, preparation method therefor, and composition comprising same for preventing, alleviating or treating neurodegenerative diseases17 Feb 2026US 12,552,779 B2Duksung Women's University Industry-Academic Cooperation Foundation
- Polymeric disinfectants and uses thereof17 Feb 2026US 12,552,882 B2Technion Research & Development Foundation Limited
- Compound, electrolyte for rechargeable lithium battery, and rechargeable lithium battery including the same28 May 2026US 2026/0149045 A1Samsung SDI.Co., Ltd.
- Cd97 and gsdme interaction inhibitor having anti-tumor activity and application thereof7 May 2026US 2026/0124202 A1Jilin University
- Organic compound, light-emitting device including the organic compound, electronic apparatus including the light-emitting device, and electronic equipment including the electronic apparatus26 Mar 2026US 2026/0090268 A1Samsung Display Co., Ltd.
- Sars-cov-2 inhibitors for treating coronavirus infections19 Feb 2026US 2026/0049062 A1Insilico Medicine IP Limited
- Synthetic retinoids for use in rar activation1 Jan 2026US 2026/0000631 A1University of Durham
Most cited
By later US patents
- Known and selected novel arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and anti-inflammatory agents80US 5,208,250 AWarner-Lambert Company · 1993
- Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties68US 5,246,943 AWarner-Lambert Company · 1993
- Olefin polymerization catalysts containing group 8-10 transition metals, processes employing such catalysts and polymers obtained therefrom50US 6,103,658 AEastman Chemical Company · 2000
- Chemical compound suitable for use as an explosive, intermediate and method for preparing the compound44US 6,312,538 B1Totalforsvarets Forskningsinstitut · 2001
- Compounds for use as chemical vapor deposition precursors, thermochromic materials light-emitting diodes, and molecular charge-transfer salts and methods of making these compounds43US 6,103,459 AMidwest Research Institute · 2000